Abdallah Geara, MD

Lafayette R, Barbour SJ, Brenner RM, Campbell KN, Doan T, Eren N, Floege J, Jha V, Kim BS, Liew A, Maes B, Pal A, Pecoits-Filho R, Phoon RKS, Rizk DV, Suzuki H, Tesař V, Trimarchi H, Wei X, Zhang H, Barratt J; ORIGIN Phase 3 Trial Investigators. A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy , NEJM, 394(7): 2026,647-657

Andreia Curto, Victor J Martinez Leon, Abdallah S Geara Daratumumab for Treatment of Refractory Podocytopathy: A Case Report , Kidney Medicine, 8(3): 2026,101253

Abdallah S Geara, Kelly B Chen, Whitney Simmons Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy , Kidney Medicine, 8(3): 2026,101242

Gerber JM, Dehdashtian E, Hu G, Gregoire C, Borie D, Bindal P, Cerny J, Geara A, Schett G, Caricchio R. Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis , Lupus Sci Med., 12(2): 2025,e001742

Ella Eisinger, Abdallah S Geara, Bryan Chang, Preethi Reddivari, Julia Ford, Ora Gewurz-Singer, Duvuru Geetha Avacopan for ANCA-associated vasculitis: Beyond the 52-week treatment course , Clinical Nephrology, 104(5): 2025,338-342

Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek J, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin D, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson EK, Wall SA, Patton JT, Barreto JN, Hermann SM, Sheikh MS, Baz RC, Lee JH, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu R, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JCQ, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE. Glucarpidase for treatment of high-dose methotrexate toxicity , Blood, 145(17): 2025,1858-1869

Keith W Hamilton, Elvis Hua, Lauren Dutcher, Holly Fernandez Lynch, Paul Junker, Abigail G Doucette, Danielle Werner, Ethan Z Kannel, Thomas Civitello, Peter Gabriel, Vivek N Ahya, Dina A Jacobs, Alfred Garfall, Keith Pratz, Kathleen O Degnan, Emily A Blumberg, Donna Capozzi, Ethan Craig, Patricia Takach, Aimee S Payne, Abdallah Geara, Helen Koenig, Lawrence Holzman, Pablo Tebas Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center , Open Forum Infectious Disease, 11(8): 2024,ofae388

Reza Zonozi 1 2, Faten Aqeel 3, Dustin Le 3, Frank B Cortazar 4, Jugal Thaker 5, Maria Jose Zabala Ramirez 6, Sebastian Eduardo Sattui Cortes 7, Rose Mary Attieh, Madeline Chung, David H Bulbin, Aisha Shaikh, Karina Guaman, Julia Ford, Colin Diffie, Ora Gewurz-Singer, Gabriel Sauvage, Anushya Jeyabalan, Abdallah Geara, Isabelle Ayoub, Andrew Bomback, Lara L Khoury, Jason C George, Kenar D Jhaveri, Vimal Kumar Derebail, John L Niles, Duvuru Geetha Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis , Kidney International Reports, 9(6): 2024,1783-1791

Michelle N Rheault 1, Charles E Alpers 1, Jonathan Barratt 1, Stewart Bieler 1, Pietro Canetta 1, Dong-Wan Chae 1, Gaia Coppock 1, Ulysses Diva 1, Loreto Gesualdo 1, Hiddo J L Heerspink 1, Jula K Inrig 1, Gianna M Kirsztajn 1, Donald Kohan 1, Radko Komers 1, Laura A Kooienga 1, Kenneth Lieberman 1, Alex Mercer 1, Irene L Noronha 1, Vlado Perkovic 1, Jai Radhakrishnan 1, William Rote 1, Brad Rovin 1, Vladimir Tesar 1, Hernán Trimarchi 1, James Tumlin 1, Muh Geot Wong 1, Howard Trachtman 1; DUPRO Steering Committee and DUPLEX Investigators Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis , NEJM, 389(26): 2023,2436-2445

Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, Charles E Alpers, Stewart Bieler, Dong-Wan Chae, Ulysses A Diva, Jürgen Floege, Loreto Gesualdo, Jula K Inrig, Donald E Kohan, Radko Komers, Laura Ann Kooienga, Richard Lafayette, Bart Maes, Robert Małecki, Alex Mercer, Irene L Noronha, Se Won Oh, Chen Au Peh, Manuel Praga, Priscila Preciado, Jai Radhakrishnan, Michelle N Rheault, William E Rote, Sydney C W Tang, Vladimir Tesar, Howard Trachtman, Hernán Trimarchi, James A Tumlin, Muh Geot Wong, Vlado Perkovic; DUPRO steering committee and PROTECT Investigators Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial , Lancet, 402(10417): 2023,2077-2090